Anti-SYNGR3 monoclonal antibody

Pre-made anti-SYNGR3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SYNGR3/SYNGR3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1868-Ab-1/ GM-Tg-hg-IP1868-Ab-2Anti-Human SYNGR3 monoclonal antibodyHuman
GM-Tg-rg-IP1868-Ab-1/ GM-Tg-rg-IP1868-Ab-2Anti-Rat SYNGR3 monoclonal antibodyRat
GM-Tg-mg-IP1868-Ab-1/ GM-Tg-mg-IP1868-Ab-2Anti-Mouse SYNGR3 monoclonal antibodyMouse
GM-Tg-cynog-IP1868-Ab-1/ GM-Tg-cynog-IP1868-Ab-2Anti-Cynomolgus/ Rhesus macaque SYNGR3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1868-Ab-1/ GM-Tg-felg-IP1868-Ab-2Anti-Feline SYNGR3 monoclonal antibodyFeline
GM-Tg-cang-IP1868-Ab-1/ GM-Tg-cang-IP1868-Ab-2Anti-Canine SYNGR3 monoclonal antibodyCanine
GM-Tg-bovg-IP1868-Ab-1/ GM-Tg-bovg-IP1868-Ab-2Anti-Bovine SYNGR3 monoclonal antibodyBovine
GM-Tg-equg-IP1868-Ab-1/ GM-Tg-equg-IP1868-Ab-2Anti-Equine SYNGR3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1868-Ab-1/ GM-Tg-hg-IP1868-Ab-2; GM-Tg-rg-IP1868-Ab-1/ GM-Tg-rg-IP1868-Ab-2;
GM-Tg-mg-IP1868-Ab-1/ GM-Tg-mg-IP1868-Ab-2; GM-Tg-cynog-IP1868-Ab-1/ GM-Tg-cynog-IP1868-Ab-2;
GM-Tg-felg-IP1868-Ab-1/ GM-Tg-felg-IP1868-Ab-2; GM-Tg-cang-IP1868-Ab-1/ GM-Tg-cang-IP1868-Ab-2;
GM-Tg-bovg-IP1868-Ab-1/ GM-Tg-bovg-IP1868-Ab-2; GM-Tg-equg-IP1868-Ab-1/ GM-Tg-equg-IP1868-Ab-2
Products NameAnti-SYNGR3 monoclonal antibody
Formatmab
Target NameSYNGR3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SYNGR3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1868-Ag-1Recombinant multi-species SNG3/ SYNGR3 protein


    Target information

    Target IDGM-IP1868
    Target NameSYNGR3
    Gene ID9143,20974,302975,694003,490062,101083732,618415,100065638
    Gene Symbol and SynonymsSYNGR3
    Uniprot AccessionO43761,A2VE58
    Uniprot Entry NameSNG3_HUMAN,SNG3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000127561
    Target ClassificationN/A

    The target: SYNGR3, gene name: SYNGR3, also named as . This gene encodes an integral membrane protein. The exact function of this protein is unclear, but studies of a similar murine protein suggest that it is a synaptic vesicle protein that also interacts with the dopamine transporter. The gene product belongs to the synaptogyrin gene family. [provided by RefSeq, Dec 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.